OOIR: Observatory of International Research

Papers

(The TQCC of European Respiratory Review is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)

Article	Citations
Cough monitoring systems in adults with chronic respiratory diseases: a systematic review	306
Reply to: “Nicotine or tobacco abstinence?”	194
European Respiratory Review, list of peer reviewers 2022	154
Ventilation/perfusion mismatch is not the sole reason for hypoxaemia in early stage COVID-19 patients	152
European Respiratory Review, list of peer reviewers 2023	133
Lost in translation: a neglected mTOR target for lymphangioleiomyomatosis	131
Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension	130
Health disparities and associated social determinants of health in interstitial lung disease: a narrative review	121
Live teleultrasound for evaluation of the chest: a systematic review	115
Association of preserved ratio impaired spirometry with mortality: a systematic review and meta-analysis	108
Exacerbations of bronchiectasis	100
The role of telemonitoring in patients on home mechanical ventilation	95
The re-emerging role of linoleic acid in paediatric asthma	88
Treatable traits in asthma during pregnancy: a call for a shift towards a precision-based management approach	83
Recovery of lung function during the first year after COVID-19: a systematic review and meta-analysis	83
Right-sided heart failure in acute respiratory distress syndrome	82
Global respiratory health priorities at the beginning of the 21st century	79
Epidemiology of severe asthma in children: a systematic review and meta-analysis	77
Context-dependent roles of palmitoylation in acute respiratory distress syndrome: integrating inflammation, cell death and repair	75
Advance care planning in patients with respiratory failure	74
Quality of life in patients with chronic respiratory failure on home mechanical ventilation	73
Multiple breath washout and oscillometry after allogenic HSCT: a scoping review	72
Lung stem cells and respiratory epithelial chimerism in transplantation	70
Inhaled corticosteroids for the treatment of COVID-19	69
Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell	69

Air pollution as an early determinant of COPD	67
Diaphragm excursion and diaphragm thickening fraction: commonality and conflict	64
Imaging technologies in experimental pulmonary fibrosis research: essential tool for enhanced translational relevance	63
Integrating asthma care guidelines into primary care electronic medical records: a review focused on Canadian knowledge translation tools	62
The ageing of people living with cystic fibrosis: what to expect now?	62
Sarcopenia in interstitial lung disease	59
Quantitative lung ultrasound in neonates: tried-and-tested systems simplify bedside use	58
Characteristics of scores used for quantitative lung ultrasound in neonates: a systematic review	56
Phenotype overlap in the natural history of asthma	55
WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension	55
Sex and gender in interstitial lung diseases	53
Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis	52
Methods to assess COPD medications adherence in healthcare databases: a systematic review	51
Harmonising cellular conversations: decoding the vital roles of extracellular vesicles in respiratory system intercellular communications	49
Recreating chronic respiratory infectionsin vitrousing physiologically relevant models	48
Prognostic biomarkers for the development of progressive pulmonary fibrosis in hypersensitivity pneumonitis: a systematic review	48
Diagnostic yield and safety of diagnostic techniques for pulmonary lesions: systematic review, meta-analysis and network meta-analysis	47
Nonpharmacological interventions in COPD	47
Smoking cessation and vaccination	45
Balancing the value and risk of exercise-based therapy post-COVID-19: a narrative review	45
Sex and gender in respiratory physiology	44
A pulmonologist's guide to perform and analyse cross-species single lung cell transcriptomics	44
Pathophysiology and genomics of bronchiectasis	44
REM sleep obstructive sleep apnoea	44
Airway ciliated cells in adult lung homeostasis and COPD	43
Mitogen-activated protein kinase-guided drug discovery for post-viral and related types of lung disease	43
Sensitivity and complications of thoracentesis and thoracoscopy: a meta-analysis	43
Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an indivi	42
Antibiotic resistance in chronic respiratory diseases: from susceptibility testing to the resistome	42
Investigating the prognostic value of digital mobility outcomes in patients with chronic obstructive pulmonary disease: a systematic literature review and meta-analysis	42
Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection	40
Advanced imaging techniques and artificial intelligence in pleural diseases: a narrative review	39
Sex and gender in pulmonary arterial hypertension	39
Extreme weather and asthma: a systematic review and meta-analysis	39
Clinical significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbations of COPD: present and future	38
Diagnostic yield and safety of transbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases: a systematic review and meta-analysis	38
Pro: Clinical remission in asthma – implications for asthma management	38
COVID-19 and tuberculosis: the double whammy of respiratory pathogens	38
Extrapulmonary effects of lung volume reduction in severe emphysema: a systematic review	37
Bronchiolar disorders in systemic autoimmune rheumatic diseases	37
Rare thoracic cancers: a comprehensive overview of diagnosis and management of small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours	36
Interplay between respiratory viruses and cilia in the airways	36
Sex and gender in lung health and disease: more than just Xs and Ys	36
Pathogenesis-driven treatment of primary pulmonary alveolar proteinosis	36
The persistent inflammation in COPD: is autoimmunity the core mechanism?	35
The oesophageal balloon for respiratory monitoring in ventilated patients: updated clinical review and practical aspects	35
Adherence-enhancing interventions for pharmacological and oxygen therapy in patients with COPD: a systematic review and component network meta-analyses	35
Subclinical tuberculosis: a meta-analysis of prevalence and scoping review of definitions, prevalence and clinical characteristics	35
Preclinical models of maternal asthma and progeny outcomes: a scoping review	33
“Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms.” S. Malenfant, M. Lebret, É. Breton-Gagnon,et al.Eur Respir Rev	32

Parasitic lung diseases	31
Positive airway pressure therapy for post-stroke sleep disordered breathing: a systematic review, meta-analysis and meta-regression	31
Natural killer cells in the lung: potential role in asthma and virus-induced exacerbation?	31
Association between second-hand smoke exposure and lung cancer risk in never-smokers: a systematic review and meta-analysis	30
Polyphenols, flavonoids and inflammasomes: the role of cigarette smoke in COPD	30
Molecular monitoring of lung allograft health: is it ready for routine clinical use?	30
Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations	30
Medication adherence to CFTR modulators in patients with cystic fibrosis: a systematic review	30
The epithelial era of asthma research: knowledge gaps and future direction for patient care	29
New trends in pulmonary hypertension	29
Does pulmonary rehabilitation address treatable traits? A systematic review	29
Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD	29
Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis	29
Bronchiectasis in Asia: a review of current status and challenges	28
Predictors of sleep disordered breathing in children with Down syndrome: a systematic review and meta-analysis	28
Effectiveness and safety of home-based versus centre-based exercise programmes for pulmonary hypertension: a systematic review with meta-analysis	28
Patient-reported outcome measures for cough used in interstitial lung disease: a systematic review	28
Fixed-intensity exercise tests to measure exertional dyspnoea in chronic heart and lung populations: a systematic review	28
Evidence-based management of symptoms in serious respiratory illness: what is in our toolbox?	27
Association between air pollution and allergic upper respiratory diseases: a meta-analysis	27
Breathing techniques to reduce symptoms in people with serious respiratory illness: a systematic review	26
Lung cancer occurrence after an episode of tuberculosis: a systematic review and meta-analysis	26
Impact of climate change on paediatric respiratory health: pollutants and aeroallergens	26
A scoping review on the risk of tuberculosis in specific population groups: can we expand the World Health Organization recommendations?	26
From treatable traits to GETomics in airway disease: moving towards clinical practice	25
“Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD”. Ariel A. Calderon, Colin Dimond, David F. Choy, Rajita Pappu, Michele A. Grimb	25
Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review	25
The association between alcohol consumption and pulmonary function: a scoping review	25
E-cigarettes and nicotine abstinence: a meta-analysis of randomised controlled trials	25
Managing an ageing cystic fibrosis population: challenges and priorities	24
Nitrogen single and multiple breath washout test and lung imaging to detect treatment-related pulmonary toxicity in paediatric cancer patients and survivors: a systematic review	24
Supplemental oxygen for symptomatic relief in people with serious respiratory illness: a systematic review and meta-analysis	24
Stem cell therapy in pulmonary hypertension: current practice and future opportunities	24
Hypoxaemia in the early stage of COVID-19: prevalence of physical or biochemical factors?	24
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis	23
Physical activity measurements in individuals with interstitial lung disease: a systematic review and meta-analysis	23
Global birth prevalence of Robin sequence in live-born infants: a systematic review and meta-analysis	23
The role of antibodies in tuberculosis diagnosis, prophylaxis and therapy: a review from the ESGMYC study group	22
Digital twins for chronic lung diseases	22
Prognostic value of echocardiography-derived right ventricular dysfunction in haemodynamically stable pulmonary embolism: a systematic review and meta-analysis	22
Biologics in severe asthma: the role of real-world evidence from registries	22